{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-108288","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.337172+00:00","generated_at":"2026-06-10T02:02:10.060546+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Cencora amends and restates revolving credit facility, extending maturity to October 2028","bullets":["Senior unsecured multi-currency Revolving Credit Facility amended to extend maturity from 2025 to October 6, 2028.","Interest margins range from 80.5 to 122.5 bps over Term SOFR/EURIBOR/CDOR based on Cencora's public debt ratings.","Facility fees range from 7 to 15 bps per annum on total commitments, also determined by debt ratings.","Letters of credit sublimit of US $100 million; proceeds used for general corporate purposes.","Customary affirmative and negative covenants, including limitations on subsidiary indebtedness and leverage ratio."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-108288","json":"https://secwatch.observer/filing/0001104659-23-108288.json","markdown":"https://secwatch.observer/filing/0001104659-23-108288.md","text":"https://secwatch.observer/filing/0001104659-23-108288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000110465923108288/0001104659-23-108288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000110465923108288/tm2327544d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:02:10.060546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7fe0938bf240936c022d1666ff219fad3ca678ad","claim":"Cencora, Inc. amended Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (effective 2023-10-06).","evidence_excerpt":"On October 6, 2023, Cencora, Inc. (the “Company”) and its subsidiaries BP Pharmaceuticals Laboratories Unlimited Company, Centaur Services Limited and Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) to amend and restate the Amended and Restated Credit Agreement, dated as of October 27, 2022, among the Company, the borrowing subsidiaries party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1140859/000110465923108288/0001104659-23-108288-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A., as administrative agent"},{"label":"Effective","value":"2023-10-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}